| Patents for C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580) |
|---|
| 04/12/2006 | CN1759115A Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 04/11/2006 | US7026352 Physiologically active substances |
| 04/11/2006 | US7026351 Cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs, compositions and uses thereof |
| 04/11/2006 | CA2248004C Process for preparing 1,6 hexanediol and caprolactone |
| 04/06/2006 | WO2006036131A1 A novel compound and a novel microorganism for producing the novel compound |
| 04/06/2006 | CA2581375A1 Specific kinase inhibitors |
| 04/05/2006 | CN1754899A Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and alpha, beta-unsaturated carboxylic acid and aldehyde compounds |
| 03/30/2006 | DE102004046024A1 Antibiotikum und Verfahren zur Herstellung Antibiotic and methods for preparing |
| 03/30/2006 | CA2582766A1 Isomigrastatin analogs in the treatment of cancer |
| 03/30/2006 | CA2581095A1 Antibiotic and method for production thereof |
| 03/29/2006 | EP1467998B1 Tetracyclic heterocompounds as estrogen receptor modulators |
| 03/23/2006 | US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 03/15/2006 | EP1448566B1 Chemokine receptor antagonists and methods of use thereof |
| 03/08/2006 | EP1328527B1 Cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including those resistant to usual chemotherapeutic agents and as reversal agents |
| 03/07/2006 | US7009061 Diterpene compounds |
| 03/01/2006 | CN1243746C Heterocyclic compound inhibiting angiogenesis |
| 02/23/2006 | US20060041007 Metastable benzoxepne derivatives which can be used in the treatment of dyslipidaemia a therosclerosis and diabetes, pharmaceutical compositions comprising them and processes for the preparation thereof |
| 02/22/2006 | CN1738824A CCR1 antagonists for the treatment of I.A. demyelinating inflammatory disease |
| 02/22/2006 | CN1243004C Tricycloacetal lactones ,preparing process and use thereof |
| 02/14/2006 | US6998256 Methods of obtaining epothilone D using crystallization and /or by the culture of cells in the presence of methyl oleate |
| 02/08/2006 | CN1732264A Borrelidin-producing polyketide synthase and its use |
| 02/08/2006 | CN1732172A Epothilone derivatives |
| 02/08/2006 | CN1240679C 2- and 2,5-substituted phenylketoenols |
| 02/02/2006 | US20060025395 Analogs of dictyostatin, intermediates therefor and methods of synthesis thereof |
| 02/02/2006 | CA2571587A1 Quaternary salt ccr2 antagonists |
| 01/26/2006 | WO2006009093A1 Medicament for preventing and/or treating sleep disorder |
| 01/26/2006 | US20060018846 Animo substituted hydroxyphenyl benzophenone derivatives |
| 01/26/2006 | CA2573915A1 Preventive and/or therapeutic agent for sleeping disorder |
| 01/25/2006 | CN1726184A Animo substituted hydroxyphenyl benzophenone derivatives |
| 01/25/2006 | CN1238323C Process for the solid phase synthesis of aldehydes, ketones, oximes, amines and hydroxamic acid compounds |
| 01/24/2006 | US6989450 Aldol condensation of a ketonic compound containing free or protected alcohol group with a acid or or metallic salt group containing compound to form intermediate, performing macrolactonizing of the intermediate |
| 01/19/2006 | US20060014825 Novel k99-5278 substance and a process for producing the same |
| 01/12/2006 | WO2006002721A1 New 5-alkenone-3,3-dimethyl-benzoxepines derivatives useful for the preparation of antidiabetic pentadienoic acids |
| 01/11/2006 | EP1613603A2 Migrastatin analogs and uses thereof |
| 01/11/2006 | CN1235925C Solid phase synthesing method of aldehyde, ketonic, oxime, amine and isohydroximic acid compound |
| 01/11/2006 | CN1235855C Process for preparation of bicyclic diketone salts |
| 01/04/2006 | CN1234704C Lactone monomer of medical macromolecule material with biodegradability and preparation process thereof |
| 12/28/2005 | EP1609786A1 New 5-alkenone-3,3-dimethyl-benzoxepines derivatives useful for the preparation of antidiabetic pentadienoic acids |
| 12/28/2005 | EP1608626A1 Migrastatin analog compositions and uses thereof |
| 12/28/2005 | EP1527076B1 Dihydro-dibenzo[b,e]oxepine based selective estrogen receptor modulators, compositions and methods |
| 12/22/2005 | WO2005103041A9 Treatment of cns disorders using cns target modulators |
| 12/15/2005 | WO2005117588A2 Analogs of dictyostatin, intermediates therefor and methods of synthesis thereof |
| 12/15/2005 | CA2568221A1 Analogs of dictyostatin, intermediates therefor and methods of synthesis thereof |
| 12/06/2005 | US6972335 useful as highly specific, non-toxic anticancer therapeutics and provides methods of inhibiting multidrug resistant cells |
| 11/30/2005 | EP1600446A1 New 3,3-dimethyl-5-cyano-benzoxepine derivatives useful for the preparation of 5-formyl-benzoxepine derivatives |
| 11/30/2005 | EP1185518B1 Alpha-phenyl-beta-ketosulfone |
| 11/24/2005 | WO2005111012A1 New 3,3-dimethyl-5-cyano-benzoxepines derivatives useful for the preparation of 5-formyl-benzoxepine derivatives |
| 11/24/2005 | US20050261277 Pentacyclic oxepines and derivatives thereof, compositions and methods |
| 11/17/2005 | US20050256183 Hsp90-inhibiting zearalanol compounds and methods of producing and using same |
| 11/16/2005 | EP0873406B1 Protein induced by deprenyl |
| 11/15/2005 | US6965034 Deoxygenation of epothilone A or B, to form desoxyepothilone used as nontoxic anticarcinogenic agents |
| 11/10/2005 | WO2005105773A1 11-methyl-13-tridecanolide, 12-methyl-14-tetradeca- nolide and 13-methyl-15-pentadecanolide, perfume compositions containing the same, and process for the production of compounds including the same |
| 11/09/2005 | EP1320611B1 Heterologous production of polyketides |
| 11/09/2005 | EP1049700B1 Chemokine receptor antagonists and methods of use therefor |
| 11/09/2005 | EP1019389B1 Epothilone derivatives |
| 11/03/2005 | WO2005103041A2 Treatment of cns disorders using cns target modulators |
| 11/03/2005 | WO2005102977A1 New 1-methoxy-2-phenyl ethenes for the preparation of 5-carboxaldehyde-2-3-dihydrobenzoxepines |
| 11/03/2005 | WO2005102313A1 Preventive and/or therapeutic agent for chronic sinusitis |
| 11/03/2005 | US20050245598 Antiproliferative activity and is most unlikely a substrate for P-glycoprotein and/or Multidrug Resistant Protein |
| 11/03/2005 | US20050245514 Novel physiologically active substances |
| 11/03/2005 | CA2564733A1 New 1-methoxy-2-phenyl ethenes for the preparation of 5-carboxaldehyde-2-3-dihydrobenzoxepines |
| 11/03/2005 | CA2563826A1 Treatment of cns disorders using cns target modulators |
| 11/03/2005 | CA2563684A1 Preventive and/or therapeutic agent for chronic sinusitis |
| 11/02/2005 | EP1591434A1 New 1-methoxy-2-phenyl ethenes useful for the preparation of 5-carboxaldehyde-2-3-dihydrobenzoxepines |
| 11/02/2005 | EP0930296B2 Fluorinated prostaglandin derivatives and medicines |
| 10/27/2005 | WO2005100329A1 Novel protecting reagents, protecting groups and methods of forming and using the same |
| 10/27/2005 | US20050240017 5-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-5,11-dihydro-6-oxa-12-thia-dibenzo[a,f]azulen-2-ol; 13-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-7,13-dihydro-12-oxa-benzo[4,5]cyclohepta[1,2-a]naphthalen-3-ol or derivatives or salts; for alleviating symptoms of estrogen deprivation, including bone loss |
| 10/26/2005 | EP1589017A2 12,13-modified epothilone derivatives |
| 10/26/2005 | EP1589011A1 Novel chiral heptyne derivates for the preparation of epothilones and processes for their preparation |
| 10/20/2005 | WO2005097104A1 SOLID PHARMACEUTICAL PREPARATION CONTAINING DIBENZ[b,e]OXEPINE DERIVATIVE |
| 10/19/2005 | EP1058679B1 Synthesis of epothilones, intermediates thereto and analogues therof |
| 10/13/2005 | WO2005068451A3 Methods for the synthesis of dictyostatin and derivatives and analogues thereof, stereochemical characterisation, novel dictyostatin compounds and uses thereof and synthetic intermediates |
| 10/12/2005 | EP1385837B1 Tricyclic alkylhydroxamates, their preparation and their use as cell proliferation inhibitors |
| 10/12/2005 | EP0977563B1 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 10/11/2005 | US6953782 antibacterial; substituted methylene in the 11 position |
| 10/06/2005 | WO2005092876A1 Synthesis of rocaglamide natural products via photochemical generation of oxidopyrylium species |
| 10/06/2005 | WO2005092323A1 PARTIAL AGONIST SPECIFIC TO LXRα RECEPTOR |
| 09/29/2005 | WO2005090337A1 Opioid receptor antagonists |
| 09/29/2005 | CA2558652A1 Opioid receptor antagonists |
| 09/27/2005 | US6949615 Monomer having electron-withdrawing group and process for preparing the same |
| 09/27/2005 | US6949291 Twisted polymers, uses thereof and processes for the preparation of statistical copolymers |
| 09/22/2005 | US20050209214 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 09/21/2005 | EP1576160A2 Borrelidin-producing polyketide synthase and its use |
| 09/21/2005 | CN1671856A Novel physiologically active substances |
| 09/21/2005 | CN1671622A Microporous crystalline zeolite material (zeolite ITQ-22), synthesis method thereof and use of same as a catalyst |
| 09/20/2005 | US6946482 Motilide compounds |
| 09/14/2005 | CN1668608A Heterodiamondoids |
| 09/07/2005 | EP1569893A2 Amino substituted hydroxyphenyl benzophenone derivatives |
| 09/07/2005 | CN1665821A 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 09/07/2005 | CN1665799A Motilide compounds |
| 09/07/2005 | CN1665780A Tricyclic steroid hormone nuclear receptor modulators |
| 09/01/2005 | WO2005079785A1 Remedies for hyperuricemia and/or gout |
| 08/31/2005 | EP1568781A2 Melanogenesis-modulating macrolides assessed by mammalian cell based activity assays |
| 08/31/2005 | EP1182200B1 Tricyclic fused heterocycle compounds, process for preparing the same and use thereof |
| 08/31/2005 | CN1660835A Compound of substituted nonane oxide-2-ketone, preparation method and application |
| 08/30/2005 | US6936724 Process for producing epsilon-caprolactone |
| 08/30/2005 | US6936723 Anticancer activity and V-ATPase inhibition; improved stability over natural benzolactones |
| 08/30/2005 | US6936402 Monomers containing an oxepan-2-one group, photoresist compositions comprising polymers prepared from the monomers, methods for preparing the compositions, and methods for forming photoresist patterns using the compositions |
| 08/25/2005 | US20050187255 Novel curcumin analogues and uses thereof |
| 08/24/2005 | CN1216052C Anti-neurodegeneratively active 10-aminoaliphatyl-dibenz (b,f) oxepines |